EN | TR
E-ISSN: 3061-9947
Inflammatory Myofibroblastic Tumor of the Breast in 64 – Year – Old Women
PDF
Cite
Share
Request
Case report
VOLUME: 55 ISSUE: 2
P: 180-185
2022

Inflammatory Myofibroblastic Tumor of the Breast in 64 – Year – Old Women

Acta Haematol Oncol Turc 2022;55(2):180-185
DOI: 10.5505/aot.2022.32848
Eda Güner 1
Fatma Markoç 2
Cihangir Özaslan 3
1. Department of General Surgery, University of Health Sciences Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Resarch Hospital
2. Department of Pathology University of Health Sciences Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Resarch Hospital
3. Department of General Surgery, Surgical Oncology Discipline, University of Health Sciences Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Resarch Hospital
4.
No information available.
No information available
Received Date: 2022-02-01T19:00:57
Accepted Date: 2022-08-01T05:58:02
PDF
Cite
Share
Request

Abstract

Introduction: The inflammatory myofibroblastic tumour (IMT) rarely located in the breast and, surgıcal resection is enough for the diagnosis and treatment. Case Report: The patient, a 64-year-old female, referred to our centre palpable mass in the right breast. Mammography demonstrated a mass of smoothed contour with calcification in the right breast. After three months later segmental mastectomy was planned as the mass grew. Pathologically features, micromorphological and immunohistochemical staining have confirmed the lesion as being breast IMT. Conclusion: IMTs of the breast is a rare and intermediate ( rarely metastasizing) malignant potential tumour. Due to recurrence and metastasis risk, complete excision with negative margins and regular follow up plays a critical role in the treatment of IMTs.